血清胰岛素样生长因子-1作为心力衰竭的潜在预后生物标志物,其弹射率降低:一个元分析
Tingting Liu1, Fangyu Li2, Yihuan Fei3
1Department of Experimental Animal Laboratory, Xuanwu Hospital of Capital Medical University, Beijing, China.
Frontiers in cardiovascular medicine
|October 2, 2024
概括
较低的胰岛素样生长因子-1 (IGF-1) 水平与心力衰竭 (HF) 有关. 这一元分析证实了这种关联,特别是在减少喷射分数 (HFrEF) 的患者中.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 生物标志物 生物标志物
背景情况:
- 周围的胰岛素样生长因子-1 (IGF-1) 水平已经显示出诊断心力衰竭 (HF) 的潜力.
- 之前的研究对IGF-1和HF之间的关联产生了不一致的结果.
- 这一元分析旨在解决关于IGF-1在HF中的作用的辩论.
研究的目的:
- 进行元分析,探索IGF-1水平与心力衰竭 (HF) 之间的关系.
- 为了研究IGF-1在HF患者的诊断价值.
主要方法:
- 在主要数据库 (Embase,Cochrane Library,PubMed,Medline,Web of Science) 进行了广泛的文献搜索,截至2023年5月30日.
- 16项相关研究,包括1380例病例和1153例对照,被选中进行元分析.
- 用随机效应模型和子组分析来评估这种关联.
主要成果:
- 在较低的IGF-1水平和HF之间发现了显著的关联 (SMD -0.598,P=0.015).
- 亚组分析表明了特定年龄和BMI组,血清样本和欧洲人口中的关联.
- 在心力衰竭中,IGF-1水平显著降低,但在心力衰竭中,IGF-1水平显著降低,但心力衰竭中,IGF-1水平显著降低,但心力衰竭中的IGF-1水平显著降低.
结论:
- 降低的IGF-1水平与HF的发生有很大的相关性.
- 需要进一步的前性研究来确定IGF-1作为HF诊断的可靠生物标志物,特别是HFrEF.
- 在考虑IGF-1用于HFpEF诊断时,建议谨慎.
相关概念视频
01:29Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
2
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
63
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
109
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
109